Search / Trial NCT00002336

The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

Launched by ABBOTT · Aug 30, 2001

Trial Information

Current as of December 26, 2024

Completed

Keywords

Mycobacterium Avium Intracellular Infection Acquired Immunodeficiency Syndrome Clarithromycin

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria
  • Patients must have:
  • HIV infection.
  • CD4 count \<= 100 cells/mm3.
  • No evidence of MAC.
  • Life expectancy of at least 6 months.
  • Exclusion Criteria
  • Concurrent Medication:
  • Excluded:
  • Certain restricted drugs (details not available).
  • Patients with the following prior conditions are excluded:
  • History of allergy or hypersensitivity to macrolides. Active substance abuse or other conditions that would affect study compliance.

About Abbott

Abbott is a global healthcare company dedicated to improving lives through innovative medical technologies, diagnostics, nutrition, and branded generic pharmaceuticals. With a commitment to advancing health and wellness, Abbott conducts clinical trials to evaluate the safety and efficacy of its diverse portfolio of products, which span multiple therapeutic areas, including cardiovascular, diabetes care, and neurology. The company employs rigorous research methodologies and collaborates with healthcare professionals and institutions worldwide to ensure the highest standards of clinical integrity and patient safety. Abbott's mission is to deliver impactful solutions that enhance patient outcomes and contribute to the advancement of global healthcare.

Locations

Houston, Texas, United States

New York, New York, United States

San Antonio, Texas, United States

Dallas, Texas, United States

Valhalla, New York, United States

Syracuse, New York, United States

Salem, Virginia, United States

Tucson, Arizona, United States

San Francisco, California, United States

San Francisco, California, United States

Tampa, Florida, United States

San Diego, California, United States

Fort Lauderdale, Florida, United States

Charlotte, North Carolina, United States

Memphis, Tennessee, United States

Hollywood, Florida, United States

Fresno, California, United States

San Jose, California, United States

Nashville, Tennessee, United States

Indianapolis, Indiana, United States

Portland, Oregon, United States

Tacoma, Washington, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials